...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1B in TNBC suspended

Just remember,,,DMcC is busting at the seams with excitiment around sharing the CUP data with us!!!,,Busting!!,,,Excited,,,and releasing the info very shortly,,,,as in not far off,,,as in soon,,,like timely,,,,,,Hahahahahahhahaha,,,,,,,this circus just never ends!!

Share
New Message
Please login to post a reply